Skip to main content
MD

Mawi DNA Technologies

Mawi DNA Technologies develops the iSWAB® biosample collection system, which stabilizes a variety of biological samples at room temperature while minimizing bacterial DNA contamination. This technology enables efficient transport and processing for genomics, proteomics, and metabolomics assays, addressing the challenges of sample integrity and contamination in diverse environments.

United StatesFounded 2013141K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional biosample collection methods often struggle with maintaining sample integrity during transport and storage, leading to inaccurate or unreliable results in downstream analyses. Bacterial DNA contamination can further compromise the accuracy of genomic, proteomic, and metabolomic assays, especially when analyzing samples from diverse environments.

Solution

Mawi DNA Technologies offers the iSWAB® biosample collection system, designed to stabilize biological samples at room temperature while minimizing bacterial DNA contamination. The iSWAB® system utilizes a non-toxic lytic buffer to selectively lyse mammalian cells, preserving high molecular weight, double-stranded genomic DNA. This technology enables efficient and reliable transport and processing of samples for various applications, including genomics, proteomics, metabolomics, and multiomics-based analysis. The iSWAB®-RC-EL is an FDA-cleared device suitable for upper respiratory tract transport, allowing for direct use without nucleic acid extraction.

Target Audience

The primary target audience includes researchers, clinicians, and diagnostic companies involved in genomics, proteomics, metabolomics, microbiome analysis, forensics, and animal science.

Features

  • iSWAB® devices stabilize DNA and RNA at ambient temperatures, reducing the need for cold chain logistics.
  • Selective lysis of mammalian cells minimizes bacterial DNA contamination, improving the accuracy of downstream analyses.
  • Non-toxic lytic buffer ensures sample integrity and safety.
  • iSWAB®-RC-EL is FDA-cleared for upper respiratory tract sample collection and transport.
  • Compatible with various downstream applications, including WGS, PCR, and microarray analysis.
  • Suitable for use with different sample types, including human, animal, and environmental samples.
  • Some kits are extraction-less, streamlining workflows and reducing processing time.
This profile is AI-generated and may contain inaccuracies.